CBIA 2023 legislative agenda focuses on workforce
The Connecticut Business & Industry Association, the state’s largest business lobby, has announced its 2023 legislative agenda, which focuses on addressing Connecticut’s workforce shortage and...
Home >
Access the latest news, business developments, company updates, industry trends, events and more.
The Connecticut Business & Industry Association, the state’s largest business lobby, has announced its 2023 legislative agenda, which focuses on addressing Connecticut’s workforce shortage and...
Torigen Pharmaceuticals of Farmington, CT, has entered into a preferred partnership agreement with VerticalVet of Cornelius, NC, to provide the VerticalVet group purchasing Organization access to Torigen....
The University of Connecticut is joining five other colleges and universities to raise money for cancer research. UConn Health will use its part of the money to...
View this email in your browser January 24, 2023 Alexion Commercial IT Project Manager New Haven Intern, Research New Haven Director, Quality Analytics and Reporting...
Please join us in thanking Peter Farina, Ph.D., for his 22 years of exceptional stewardship as a director and co-chair of BioCT’s board. Throughout his...
View this email in your browser January 19, 2023 Only 1 Month Away: BIO CEO & Investor Conference Now in it’s 25th year, the BIO CEO...
The University of Connecticut earned a slot in the top ten 4-year public higher education institutions in the nation with the best graduation rates, ranking 5th in...
Many Connecticut colleges in 2023 will continue to focus on bouncing back from declining enrollment and financial challenges brought on by the pandemic, which forced...
UConn TCS (Technology Commercialization Services) has published its annual report for 2022. “TCS’s success can be illustrated through our stories of inventorship but also through the...
BioXcel Therapeutics has announced promising top-line data from its Phase 2 trial of BXCL701, the company’s investigational, oral innate immune activator, in combination with KEYTRUDA® (pembrolizumab) in...